Announcment!, page-24

A little bit of urgency now creeping in....I can smell the anticipation in the air.

Kentgrove Capital are providing A$20 million of equity capital to GTG....you'd wanna be sure of some good progress if your taking script.

From the ann:

….Proceeds from the Facility will be used for general working capital purposes and to fund the Company’s activities as it seeks to: 

- commercialise existing R&D capabilities, IP and introduce an enhanced BREVAGenplus breast cancer risk assessment test and a colon cancer risk assessment test; 

- progress development of a suite of genetic screening tests targeting both cancer and nononcological diseases utilising the latest technology and platforms, and 

- explore and capitalise on Blockchain opportunities in the medical and biotech industries